NCT03583775

Brief Summary

Conventional CMR is based on breath-hold 2D cine image acquisitions which are sequentially acquired in different imaging planes. The necessity of precisely planning and then acquiring multiple 2D imaging planes during breath-hold is relatively inefficient and leads to CMR exam times of ≤60 minutes. However, some patients are too ill or young to hold their breath. Furthermore, 2D images sometimes fail to provide a complete picture of complex 3D anatomy of patients with complex morphology. To address these limitations, we have recently developed a 3D cine (3 spatial dimensions plus time) CMR technique. Rather than acquiring 2D cine images in multiple orientations during breath-hold, this approach allows one to acquire a free-breathing 3D block of data for each phase of cardiac cycle that can be reformatted offline into the desired views without adding to the exam time. This added efficiency should lead to a reduction in CMR exam time, increasing patient comfort, and making CMR exam easy and available for all. In addition, the 3D nature of the data may yield more complete information about the anatomy and physiology. In this proposal, we will examine the agreement between the 2D cine and 3D cine CMR techniques with regard to left and right ventricular volumes and systemic and pulmonary blood flow circulation. The internal consistency of the measurements between the 2 techniques will be also investigated. This study will focus on children because they may benefit the most from the short, improved efficiency, and free-breathing CMR exams.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 11, 2018

Completed
1.3 years until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2021

Completed
Last Updated

March 21, 2022

Status Verified

March 1, 2022

Enrollment Period

1.8 years

First QC Date

June 27, 2018

Last Update Submit

March 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • End-diastolic and end-systolic volumes of right and left ventricles

    1 day

Study Arms (1)

Patients with congenital heart disease

Patients with congenital heart disease who are greater than 40 kg and are referred for a clinically indicated 2D CMR exam with a gadolinium-based contrast agent.

Other: Cardiovascular Magnetic Resonance Imaging

Interventions

Cardiovascular Magnetic Resonance Imaging or MRI exam from children's with congenital heart disease

Patients with congenital heart disease

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with different races and ethnicity are included in the study.

You may qualify if:

  • Patients who are greater than 40 kg and are referred for a clinically indicated 2D CMR exam with a gadolinium-based contrast agent. Informed consent/assent will be obtained.

You may not qualify if:

  • Patients who are under anesthesia, sedated, or with a contraindication to CMR exams.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Tarek Alsaied

Cincinnati, Ohio, 45229, United States

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

June 27, 2018

First Posted

July 11, 2018

Study Start

November 1, 2019

Primary Completion

September 4, 2021

Study Completion

October 4, 2021

Last Updated

March 21, 2022

Record last verified: 2022-03

Locations